CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 10-K Report Annual Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Other acquisition Chief Executive Officer acquired 986,777 shares (other)
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice · Executive or director change
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale 10% owner sold 100,000 shares at an average $0.30 ($29,550)
- 4 Open-market sale 10% owner sold 100,000 shares at an average $0.30 ($29,550)
- 4 Open-market sale 10% owner sold 100,000 shares at an average $0.30 ($29,550)
- 4 Open-market sale 10% owner sold 100,000 shares at an average $0.30 ($29,550)
- SC 13D/A Stake Beneficial Ownership Report
Page 26 of 53 · 1,057 filings